<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01514227</url>
  </required_header>
  <id_info>
    <org_study_id>NIPPON 5.0</org_study_id>
    <nct_id>NCT01514227</nct_id>
  </id_info>
  <brief_title>Nobori Dual Antiplatelet Therapy as Appropriate Duration</brief_title>
  <official_title>Nobori Dual Antiplatelet Therapy as Appropriate Duration.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Associations for Establishment of Evidence in Interventions</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Associations for Establishment of Evidence in Interventions</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      NIPPON trial is a prospective, randomized, trial comparing 6 and 18 months Dual Antiplatelet
      Therapy (DAPT) following Nobori stent deployment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Net adverse clinical and cerebral event (NACCE)</measure>
    <time_frame>18 months</time_frame>
    <description>NACCE include all-cause death, non-fatal myocardial infarction, cerebrovascular events, and major bleeding.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause death</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-fatal myocardial infarction</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebrovascular events</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of target lesion revascularization</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minor bleeding</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3773</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Short-term DAPT (6 months) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 months DAPT (aspirin and thienopyridine) prescription following Nobori stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long-term DAPT (18 months) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>18 months DAPT (aspirin and thienopyridine) prescription following Nobori stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin or thienopyridine</intervention_name>
    <description>Subjects randomized 6 month DAPT will be prescribed either aspirin or thienopyridine (clopidogrel or ticlopidine) following 6 months DAPT for the duration of study, which is left on the physician's discretion.</description>
    <arm_group_label>Short-term DAPT (6 months) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin and thienopyridine</intervention_name>
    <description>Subjects randomized 18 month DAPT will be prescribed both aspirin and thienopyridine (clopidogrel or ticlopidine) for 18 month after stenting.</description>
    <arm_group_label>Long-term DAPT (18 months) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects &gt; 20 years old

          -  Undergoing percutaneous intervention with Nobori deployment

          -  No contraindication to prolonged DAPT

        Exclusion Criteria:

          -  Subjects absolutely necessitating continuous DAPT

          -  Planned surgery necessitating discontinuation of antiplatelet therapy after
             enrollment.

          -  Active pathological bleeding

          -  Status of cardiogenic shock at enrollment

          -  Pregnant women

          -  Life expectancy of &lt; 1.5 years

          -  Subjects unable to give informed consent

          -  Episode of stroke &lt; 6 months

          -  Subjects with allergies or hypersensitivity to material of coating, Biolimus A9, and
             antiplatelet drugs.

          -  Subjects treated with other kind of DES or BMS during the index procedure

          -  Previous intervention with DES &lt; 6 months.

          -  Study participation impractical per investigator judgment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Non-profit organization Associations for Establishment of Evidence in Interventions</name>
      <address>
        <city>Minato-ku</city>
        <state>Tokyo</state>
        <zip>105-0013</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2011</study_first_submitted>
  <study_first_submitted_qc>January 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2012</study_first_posted>
  <last_update_submitted>January 26, 2017</last_update_submitted>
  <last_update_submitted_qc>January 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

